Nitric oxide synthase inhibitors modulate lipopolysaccharide-induced hepatocyte injury: dissociation between in vivo and in vitro effects
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
14555288
DOI
10.1016/s1567-5769(03)00185-1
PII: S1567-5769(03)00185-1
Knihovny.cz E-zdroje
- MeSH
- alanintransaminasa krev MeSH
- dusitany analýza MeSH
- guanidiny farmakologie MeSH
- hepatocyty účinky léků metabolismus patologie MeSH
- inhibitory enzymů farmakologie MeSH
- interferon gama farmakologie MeSH
- interleukin-1 farmakologie MeSH
- játra účinky léků metabolismus patologie MeSH
- krysa rodu Rattus MeSH
- kultivované buňky MeSH
- lipopolysacharidy farmakologie toxicita MeSH
- messenger RNA účinky léků genetika metabolismus MeSH
- NG-nitroargininmethylester farmakologie MeSH
- penicilamin analogy a deriváty farmakologie MeSH
- potkani Wistar MeSH
- regulace genové exprese enzymů účinky léků MeSH
- synthasa oxidu dusnatého, typ II MeSH
- synthasa oxidu dusnatého antagonisté a inhibitory genetika MeSH
- takrolimus farmakologie MeSH
- TNF-alfa farmakologie MeSH
- viabilita buněk účinky léků MeSH
- zvířata MeSH
- Check Tag
- krysa rodu Rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- alanintransaminasa MeSH
- dusitany MeSH
- guanidiny MeSH
- inhibitory enzymů MeSH
- interferon gama MeSH
- interleukin-1 MeSH
- lipopolysacharidy MeSH
- messenger RNA MeSH
- NG-nitroargininmethylester MeSH
- Nos2 protein, rat MeSH Prohlížeč
- penicilamin MeSH
- pimagedine MeSH Prohlížeč
- S-nitro-N-acetylpenicillamine MeSH Prohlížeč
- synthasa oxidu dusnatého, typ II MeSH
- synthasa oxidu dusnatého MeSH
- takrolimus MeSH
- TNF-alfa MeSH
Effects of endotoxemia-induced NO production on rat liver and hepatocytes in culture were investigated. Rats were treated intraperitoneally with saline, lipopolysaccharide (LPS, 10 mg/kg), L-nitroarginine methyl ester (L-NAME)+LPS, aminoguanidine (AG)+LPS, FK 506+LPS, S-nitroso-N-acetyl penicillamine (SNAP)+L-NAME+LPS and SNAP+FK 506+LPS. Mortality, hepatocyte viability and liver function test were estimated. Liver morphology was observed by light and electron microscopy. Hepatocyte cultures were treated with LPS, cytokine mixture (CM) with or without FK 506, L-NAME or AG. Hepatocyte function and inducible form of NOS (iNOS) expression were evaluated. Twenty-four hours after treatments with saline, LPS, L-NAME+LPS, AG+LPS, FK 506+LPS, SNAP+L-NAME+LPS and SNAP+FK 506+LPS, rat mortalities were 0%, 10%, 48%, 8%, 20%, 38% and 0%, and hepatocyte viabilities were 93+/-3%, 80+/-3%, 52+/-8%, 88+/-1%, 70+/-3%, 80+/-4% and 82+/-3%, respectively. AG+LPS or L-NAME+LPS administration was followed by excessive vacuolization of hepatocytes with lesions in the intermediary lobule zone characterized by features of secondary necrosis as a continuation of apoptotic processes. SNAP+L-NAME+LPS resulted in a well-preserved structure of central vein lobules with sparse signs of apoptosis. Treatment with LPS or CM increased iNOS expression in hepatocyte culture, which was inhibited by L-NAME, FK 506 or AG. AG reduced LPS-induced rise in alanine aminotransferase leakage. LPS-induced NO exerts cytoprotective effects in vivo, while LPS-induced NO in vitro appears to be toxic. Based on the data of this report, one cannot use in vitro results to predict in vivo responses to LPS-induced NO production. The pharmacological modulation of iNOS expression or NO production in vivo or in vitro, therefore, by the development of specific NO donors or inhibitors is promising for improvement of hepatocyte functions under the two experimental conditions, respectively.
Citace poskytuje Crossref.org